Literature DB >> 22831870

Classification of lymphatic-system malformations in primary lymphoedema based on MR lymphangiography.

N F Liu1, Z X Yan, X F Wu.   

Abstract

OBJECTIVES: The study aims to investigate lymphatic-system malformations and proposes a classification of primary lymphoedema based on comprehensive imaging data of both lymph vessel- and lymph-node abnormalities.
MATERIALS AND METHODS: A total of 378 patients with primary lymphoedema of the lower extremity were examined with magnetic resonance lymphangiography (MRL) using gadobenate dimeglumine as contrast agent. Lymph vessels and drainage lymph nodes were evaluated, leading to the proposal of the classification of primary lymphoedema and the relative proportions.
RESULTS: A total of 63 (17%) patients exhibited defects of the inguinal lymph nodes with mild or moderate dilatation of afferent lymph vessels. A total of 123 (32%) patients exhibited lymphatic anomalies as lymphatic aplasia, hypoplasia or hyperplasia with no obvious defect of the drainage lymph nodes. The involvement of both lymph vessel- and lymph-node abnormalities in the affected limb was found in 192 (51%) patients. The primary lymphoedema was classified as three major types as: (1) lymph nodes affected only; (2) lymph vessel affected only with three subtypes and (3) both lymph vessel and lymph node affected with subgroups.
CONCLUSIONS: A comprehensive classification of lymphatic-system malformation in primary lymphoedema is proposed, which clearly defines the location and pathologic characteristics of both lymphatics and lymph node and may lead to further study of the aetiology as well as rational treatment of the disease.
Copyright © 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22831870     DOI: 10.1016/j.ejvs.2012.06.019

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  9 in total

1.  Functional lymphatic collectors in breast cancer-related lymphedema arm.

Authors:  Ning-fei Liu; Bing-shun Wang
Journal:  Lymphat Res Biol       Date:  2014-12       Impact factor: 2.589

Review 2.  New diagnostic modalities in the evaluation of lymphedema.

Authors:  Thomas F O'Donnell; John C Rasmussen; Eva M Sevick-Muraca
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2017-01-16

Review 3.  Imaging of the Lymphatic Vessels for Surgical Planning: A Systematic Review.

Authors:  Saskia van Heumen; Jonas J M Riksen; Wichor M Bramer; Gijs van Soest; Dalibor Vasilic
Journal:  Ann Surg Oncol       Date:  2022-09-28       Impact factor: 4.339

Review 4.  Emerging lymphatic imaging technologies for mouse and man.

Authors:  Eva M Sevick-Muraca; Sunkuk Kwon; John C Rasmussen
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

5.  Giant elephantiasis neuromatosa in the setting of neurofibromatosis type 1: A case report.

Authors:  Giovanni Ponti; Giovanni Pellacani; Davide Martorana; Victor Desmond Mandel; Pietro Loschi; Annamaria Pollio; Annarita Pecchi; Cristina Dealis; Stefania Seidenari; Aldo Tomasi
Journal:  Oncol Lett       Date:  2016-04-19       Impact factor: 2.967

Review 6.  Pediatric lymphatic malformations: evolving understanding and therapeutic options.

Authors:  Ann M Defnet; Naina Bagrodia; Sonia L Hernandez; Natalie Gwilliam; Jessica J Kandel
Journal:  Pediatr Surg Int       Date:  2016-01-27       Impact factor: 1.827

Review 7.  [MR Lymphangiography].

Authors:  Sang Hoon Lee; Joon Pio Hong
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2020-01-31

8.  Elephantiasis nostras verrucosa.

Authors:  Rafi Fredman; Mayer Tenenhaus
Journal:  Eplasty       Date:  2012-10-12

9.  Systematic Review of Magnetic Resonance Lymphangiography From a Technical Perspective.

Authors:  Michael Mills; Malou van Zanten; Marco Borri; Peter S Mortimer; Kristiana Gordon; Pia Ostergaard; Franklyn A Howe
Journal:  J Magn Reson Imaging       Date:  2021-02-24       Impact factor: 4.813

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.